The burden of kidney disease: Improving global outcomes
Garabed Eknoyan(Tufts Medical Center), Haiyan Wang(Baylor College of Medicine), Adeera Levin(University of British Columbia), Alison M. MacLeod(University of Aberdeen), Kai‐Uwe Eckardt(Friedrich-Alexander-Universität Erlangen-Nürnberg), Francesco Locatelli(University of Modena and Reggio Emilia), Raymond Vanholder(Ghent University Hospital), Nathan W. Levin(Renal Research Institute), Rowan G. Walker(Baylor College of Medicine), Norbert Lameire(Ghent University Hospital), Rashad S. Barsoum(Baylor College of Medicine)
Cited by 521
Related Papers
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
|Annals of Internal Medicine|2003|4.6k
Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
|Kidney International|2005|3.9k
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third national health and nutrition examination survey
|American Journal of Kidney Diseases|2002|2.8k